AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/coms2/summary_0286-26673628_ITM" title="Facts and information about Axxima Pharmaceuticals AG, of Martinsried, Germany, and BioFocus plc, of Sittingbourne, UK, entered a drug discovery collaboration. (Other News To Note).">Axxima Pharmaceuticals AG, of Martinsried, Germany, and BioFocus plc, of Sittingbourne, UK, entered a drug discovery collaboration. (Other News To Note).</a>

Close Set up an RSS feed that alerts you when new articles from BioWorld International are available.

Frequently asked questions about RSS feeds

Axxima Pharmaceuticals AG, of Martinsried, Germany, and BioFocus plc, of Sittingbourne, UK, entered a drug discovery collaboration. (Other News To Note).

BioWorld International

| July 24, 2002 | COPYRIGHT 2003 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Axxima Pharmaceuticals AG, of Martinsried, Germany, and BioFocus plc, of Sittingbourne, UK, entered a drug discovery collaboration. Axxima will provide proprietary kinase targets to BioFocus, which will then design high-throughput screening assays for the targets. BioFocus will expand and optimize any leads developed through the …

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


GPC Biotech and Ingenium receive joint drug discovery grant from German...: Newspaper article from: BIOTECH Patent News April 1, 2005 700+ words
...drugs, and Ingenium Pharmaceuticals AG (Martinsried/Munich...support collaborative drug discovery efforts with the...is leveraging its drug discovery technologies to elucidate...is a multi-year drug discovery and development collaboration...biotech.com Ingenium ...


Collaboration expanded for target characterization, drug discovery.(Cambridge...: Newspaper article from: Immunotherapy Weekly October 2, 2002 700+ words
...Cambridge Antibody Technology (CATG; CAT) and Xerion Pharmaceuticals AG announced the expansion of their existing business relationship...research collaboration for target characterization and drug discovery. CAT and Xerion will explore and evaluate the therapeutic...


Graffinity Pharmaceuticals AG Appoints New Chief Executive Officer; Dr. Klaus...: Press release article from: PR Newswire December 9, 2002 700+ words
...Germany -- Graffinity Pharmaceuticals AG ("Graffinity") announced...Graffinity's evolution into a drug discovery and development company...Graffinity Pharmaceuticals is a drug discovery and development company...its chemical microarray drug discovery platform now fully ...


Graffinity Pharmaceuticals AG appoints new Chief Executive Officer.: Press release article from: PR Newswire December 9, 2002 700+ words
...it evolves into a drug discovery and development company...Germany - Graffinity Pharmaceuticals AG ("Graffinity...evolution into a drug discovery and development company...Pharmaceuticals is a drug discovery and development company...


Santhera Pharmaceuticals AG Completes First Round of Financing Raising Euro 14...: Press release article from: PR Newswire December 17, 2004 700+ words
...organizations Graffinity Pharmaceuticals AG and MyoContract AG, since...Privately-held Santhera Pharmaceuticals AG is a drug discovery and development company...MyoContract AG and Graffinity Pharmaceuticals AG. The company is focused...


Santhera Pharmaceuticals AG completes first round of financing raising EUR 14 M.: News wire article from: Asia Africa Intelligence Wire December 17, 2004 700+ words
...Press Release) Santhera Pharmaceuticals AG has completed the second...organisations Graffinity Pharmaceuticals AG and MyoContract AG, since...metabolic diseases. Santhera Pharmaceuticals AG is a drug discovery and development company...


NADAG and SiREEN Announce Merger to Form SIRENADE Pharmaceuticals AG and Launch...: Press release article from: PR Newswire January 13, 2004 700+ words
...merge to form SIRENADE Pharmaceuticals AG, an integrated drug discovery and development company...SiREEN AG is a preclinical drug discovery company that combines...de/ (2). NADAG is a drug discovery company with clinical...


NADAG and SiREEN merge to form drug discovery/development company.: Newspaper article from: Pharma Business Week February 9, 2004 700+ words
...Germany-based biotech companies, have announced their agreement to merge to form SIRENADE Pharmaceuticals, AG, an integrated drug discovery and development company with clinical and preclinical projects in central nervous system and oncology...


Santhera spins out Graffinity through management buyout.(Santhera...: Newspaper article from: BioWorld International Sheridan, Cormac January 4, 2006 700+ words
Santhera Pharmaceuticals AG divested its drug discovery unit via a management buyout in order to focus on its clinical and preclinical development pipeline. The move revives the Graffinity...


Axxima Pharmaceuticals AG completes #10 M financing round.: News wire article from: Asia Africa Intelligence Wire June 29, 2004 700+ words
...Press Release) Axxima Pharmaceuticals AG closed a new private financing...financing rounds of the drug discovery and development kinase...applications. Axxima Pharmaceuticals AG is a unique drug discovery and development company...

For more facts and information, see all results

Source: HighBeam Research, Axxima Pharmaceuticals AG, of Martinsried, Germany, and BioFocus plc,...

The AccessMyLibrary advertising network includes: